4.7 Article

Synergistic Upregulation of Target Genes by TET1 and VP64 in the dCas9-SunTag Platform

Journal

Publisher

MDPI
DOI: 10.3390/ijms21051574

Keywords

CRISPR/Cas9; dCas9; SunTag; Tet1; VP64

Funding

  1. Platform Project for Supporting Drug Discovery and Life Science Research (Basis for Supporting Innovative Drug Discovery and Life Science Research (BINDS)) from AMED [JP19am0101120]
  2. JSPS KAKENHI [17H03613, 19K06607, 19H03143]
  3. Takeda Science Foundation
  4. Tokyo Biochemical Research Foundation
  5. Grants-in-Aid for Scientific Research [17H03613, 19K06607, 19H03143] Funding Source: KAKEN

Ask authors/readers for more resources

Overexpression of a gene of interest is a general approach used in both basic research and therapeutic applications. However, the conventional approach involving overexpression of exogenous genes has difficulty achieving complete genome coverage, and is also limited by the cloning capacity of viral vectors. Therefore, an alternative approach would be to drive the expression of an endogenous gene using an artificial transcriptional activator. Fusion proteins of dCas9 and a transcription activation domain, such as dCas9-VP64, are widely used for activation of endogenous genes. However, when using a single sgRNA, the activation range is low. Consequently, tiling of several sgRNAs is required for robust transcriptional activation. Here we describe the screening of factors that exhibit the best synergistic activation of gene expression with TET1 in the dCas9-SunTag format. All seven factors examined showed some synergy with TET1. Among them, VP64 gave the best results. Thus, simultaneous tethering of VP64 and TET1 to a target gene using an optimized dCas9-SunTag format synergistically activates gene expression using a single sgRNA.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available